Pharmaceuticals occupiers in Berlin typically cluster in Charlottenburg & Westend, plan ~220 sqft per seat at high-end fit-out ($135–200/sqft), and pay around 44 EUR/sqft ($53 USD) on Class A.
Pharmaceuticals occupiers in Berlin typically cluster in Charlottenburg & Westend, plan ~220 sqft per seat at high-end fit-out">fit-out ($135–200/sqft), and pay around 44 EUR/sqft ($53 USD) on Class A.
Pharmaceuticals occupiers in Berlin typically anchor in Charlottenburg & Westend. Banking, law, professional services, retail HQs.
Class A rent in Berlin runs 44 EUR/sqft ($53 USD) on a 5-year lease with 4 months free. Prime submarkets sit at or modestly above the city index.
Typical pharmaceuticals fit-out targets high-end specification at $135–200/sqft. Branded reception, full client-facing programming, premium furniture, and specialist AV are standard.
Plan around 220 sqft per seat blended (workstation + circulation + amenity). A 100-headcount pharma office in Berlin typically targets 22,000 sqft of leasable area.
Commercial and medical-affairs teams cluster near academic-medical anchors; large floor plates support cross-functional brand teams. Deepest tech and creative talent pool in Germany. Strong feed from TU Berlin, HU, FU, and the rapidly growing Hertie School. Multilingual talent base supports non-German European HQs.
Headline corporate tax: 30%. Net leases dominate. 5-10 year terms; tenants frequently negotiate break options at year 3 or 5. Free rent of 3-6 months on a 5-year deal; TI of €60-€100/sqm typical.
| city | Berlin |
|---|---|
| industry | Pharmaceuticals |
| naics | 3254, 5417 |
| preferredSubmarket | Charlottenburg & Westend |
| preferredFitoutSpec | High-end |
| fitoutBand | $135–200/sqft |
| sqftPerSeat | 220 |
| classARentLocal | 44 EUR/sqft/yr |
| classARentUsd | $53/sqft/yr |
| vacancyPct | 7.4% |
| typicalLeaseYears | 5 |
| typicalRentFreeMonths | 4 |
| talentIndex | 88 |
| corporateTaxPct | 30% |
Reviewed by Samuel Okafor — EMEA contributing editor. Last updated 2026-04-15. See our methodology and editorial standards.